GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clarity Pharmaceuticals Ltd (ASX:CU6) » Definitions » Other Current Liabilities

Clarity Pharmaceuticals (ASX:CU6) Other Current Liabilities : A$0.91 Mil (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Clarity Pharmaceuticals Other Current Liabilities?

Clarity Pharmaceuticals's other current liabilities for the quarter that ended in Dec. 2023 was A$0.91 Mil.

Clarity Pharmaceuticals's quarterly other current liabilities declined from Dec. 2022 (A$0.86 Mil) to Jun. 2023 (A$0.80 Mil) but then increased from Jun. 2023 (A$0.80 Mil) to Dec. 2023 (A$0.91 Mil).

Clarity Pharmaceuticals's annual other current liabilities increased from . 20 (A$0.00 Mil) to Jun. 2022 (A$0.71 Mil) and increased from Jun. 2022 (A$0.71 Mil) to Jun. 2023 (A$0.80 Mil).

Clarity Pharmaceuticals Other Current Liabilities Historical Data

The historical data trend for Clarity Pharmaceuticals's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clarity Pharmaceuticals Other Current Liabilities Chart

Clarity Pharmaceuticals Annual Data
Trend Jun22 Jun23
Other Current Liabilities
- -

Clarity Pharmaceuticals Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23
Other Current Liabilities Get a 7-Day Free Trial - - - - -

Clarity Pharmaceuticals Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

Clarity Pharmaceuticals Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Clarity Pharmaceuticals's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Clarity Pharmaceuticals (ASX:CU6) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clarity Pharmaceuticals Ltd (ASX:CU6) » Definitions » Other Current Liabilities
Comparable Companies
ASX:IMU ASX:MSB ASX:OPT ASX:PYC ASX:BOT ASX:IMM ASX:RAC ASX:PAR ASX:PIQ ASX:RCE OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
CLRPF:USA
Address
4 Cornwallis Street, National Innovation Centre, Eveleigh, Sydney, NSW, AUS, 2015
Website
https://www.claritypharmaceuticals.com
Clarity Pharmaceuticals Ltd is a clinical-stage radiopharmaceutical company developing next-generation theranostic (therapy and imaging) products, based on its platform SAR Technology. The SAR technology is ideally suited for use with copper isotopes, enabling superior imaging and therapeutic characteristics of radiopharmaceutical products and addressing the current manufacturing and logistical limitations in the growth of the radiopharmaceutical sector in oncology.

Clarity Pharmaceuticals (ASX:CU6) Headlines

No Headlines